Odyssean LLC’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.57M Buy
256,607
+132,109
+106% +$1.22M 0.3% 149
2026
Q2
$1.04M Buy
+124,498
New +$1.13M 0.17% 208
2026
Q1
– Sell
-31,296
Closed -$571K – 420
2025
Q4
$571K Buy
+31,296
New +$527K 0.41% 151

Other funds holding ADMA

Odyssean LLC's ADMA Position: Q3 2026 in Review

Odyssean LLC increased its ADMA Biologics (ADMA) stake by 106% in Q3 2026, buying an estimated $1.22M and bringing the position to 256,607 shares worth $2.57M. The position accounts for 0.3% of the portfolio, ranked #149.

Odyssean LLC first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Odyssean LLC held 256,607 shares of ADMA Biologics worth $2.57M as of Q3 2026.
  • Odyssean LLC bought 132,109 ADMA Biologics shares in Q3 2026, an estimated $1.22M.
  • ADMA Biologics made up 0.3% of Odyssean LLC's portfolio in Q3 2026, its #149 holding.
  • Odyssean LLC first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.